Residual risks of liver cancer persist after hepatitis C cure, finds study

Cumulative incidence of HCC with 95% CI in patients with MASLD with different hepatic steatosis grades. Credit: Gut (2026). DOI: 10.1136/gutjnl-2025-337275

Continue Reading


News Source: medicalxpress.com

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *